Related Experiment Video
Updated: Aug 17, 2026
Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
Gene transfer with cationic lipid into human hepatocellular carcinoma in nude mice
1Department of Surgery II, Nagoya University School of Medicine, Japan. akane@he.mirai.ne.jp
Background/Aims:
Using a cationic lipid, gene transfection into the tumor of a human hepatocellular carcinoma model in nude mice was attempted in order to explore the possibility of its use in gene therapy.
Methodology:
A DNA-lipid complex was made by combining the cationic lipid distearyldimethyl ammonium bromide (DDAB) with pCMV sPORT expressing the reporter gene LacZ. The expression of this complex was first investigated in vitro against the human hepatocellular carcinoma cell line Li7HM. It was then injected directly into a hepatocellular carcinoma model tumor created by implanting Li7HM into the liver of BALB/c nu/nu mice, and the expression of LacZ was histologically evaluated.
Results:
LacZ gene was expressed in Li7HM in vitro with the optimized DNA-lipid complex. Cell toxicity was not a problem. Expression of LacZ was also seen in the mouse hepatocellular model tumor into which the complex had been injected, indicating successful gene transfection with this method.
Conclusions:
Direct injection of a DNA-lipid complex into a mouse hepatocellular carcinoma model tumor is a safe and simple method of gene transfection, proving this to be a viable method of transfer for use in gene therapy.
Insights
Researchers explored gene therapy for liver cancer by transfecting tumors with a DNA-lipid complex. This safe and effective method successfully delivered the LacZ gene into hepatocellular carcinoma models in mice.
Area of Science:
- Oncology
- Gene Therapy
- Biotechnology
Background:
- Hepatocellular carcinoma (HCC) is a significant global health concern.
- Gene therapy offers a promising avenue for cancer treatment.
- Effective gene delivery to tumor sites remains a challenge.
Purpose of the Study:
- To investigate the feasibility of gene transfection into HCC tumors using a cationic lipid-DNA complex.
- To evaluate the safety and efficacy of this gene delivery method in a preclinical model.
Main Methods:
- A DNA-lipid complex was formulated using distearyldimethyl ammonium bromide (DDAB) and the reporter gene LacZ.
- In vitro transfection was performed on the human HCC cell line Li7HM.
- Direct intratumoral injection of the complex was administered to a mouse HCC model (Li7HM in BALB/c nu/nu mice).
- LacZ gene expression was assessed histologically.
Main Results:
- Successful LacZ gene expression was achieved in vitro using the optimized DNA-lipid complex.
- The DNA-lipid complex demonstrated no significant cell toxicity.
- Histological evaluation confirmed LacZ gene expression within the tumors of the mouse model, indicating successful in vivo gene transfection.
Conclusions:
- Direct intratumoral injection of DNA-lipid complexes is a safe and straightforward method for gene transfection.
- This approach represents a viable strategy for gene delivery in the context of hepatocellular carcinoma gene therapy.
- The study supports the potential of this method for future clinical applications in liver cancer treatment.
